These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21132437)

  • 1. The Inventory Of Depressive Symptomatology (IDS-C(28)) is more sensitive to changes in depressive symptomatology than the Hamilton Depression Rating Scale (HAMD(17)) in patients with mild major, minor or subsyndromal depression.
    Helmreich I; Wagner S; Mergl R; Allgaier AK; Hautzinger M; Henkel V; Hegerl U; Tadić A
    Eur Arch Psychiatry Clin Neurosci; 2011 Aug; 261(5):357-67. PubMed ID: 21132437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression.
    Helmreich I; Wagner S; Mergl R; Allgaier AK; Hautzinger M; Henkel V; Hegerl U; Tadić A
    Eur Arch Psychiatry Clin Neurosci; 2012 Jun; 262(4):291-304. PubMed ID: 21959915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation.
    Trivedi MH; Rush AJ; Ibrahim HM; Carmody TJ; Biggs MM; Suppes T; Crismon ML; Shores-Wilson K; Toprac MG; Dennehy EB; Witte B; Kashner TM
    Psychol Med; 2004 Jan; 34(1):73-82. PubMed ID: 14971628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of atypical depression: post-hoc analysis of a randomized controlled study testing the efficacy of sertraline and cognitive behavioural therapy in mildly depressed outpatients.
    Henkel V; Mergl R; Allgaier AK; Hautzinger M; Kohnen R; Coyne JC; Möller HJ; Hegerl U
    Eur Psychiatry; 2010 Dec; 25(8):491-8. PubMed ID: 20965118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has the symptom severity inclusion requirement narrowed the definition of major depressive disorder in antidepressant efficacy trials?
    Zimmerman M; Walsh E; Chelminski I; Dalrymple K
    J Affect Disord; 2017 Mar; 211():60-64. PubMed ID: 28088058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
    Vaccarino AL; Evans KR; Sills TL; Kalali AH
    Depress Anxiety; 2008; 25(12):1006-13. PubMed ID: 18800370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.
    Tadić A; Helmreich I; Mergl R; Hautzinger M; Kohnen R; Henkel V; Hegerl U
    J Affect Disord; 2010 Jan; 120(1-3):86-93. PubMed ID: 19428118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorder.
    Brown ES; Murray M; Carmody TJ; Kennard BD; Hughes CW; Khan DA; Rush AJ
    Ann Allergy Asthma Immunol; 2008 May; 100(5):433-8. PubMed ID: 18517074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical differences between early and late remission in depressive patients.
    Roca M; García-Toro M; García-Campayo J; Vives M; Armengol S; García-García M; Asensio D; Gili M
    J Affect Disord; 2011 Nov; 134(1-3):235-41. PubMed ID: 21676465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.
    Rush AJ; Trivedi MH; Ibrahim HM; Carmody TJ; Arnow B; Klein DN; Markowitz JC; Ninan PT; Kornstein S; Manber R; Thase ME; Kocsis JH; Keller MB
    Biol Psychiatry; 2003 Sep; 54(5):573-83. PubMed ID: 12946886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence and severity of depressive symptoms along the spectrum of unipolar depressive disorders: a post hoc analysis.
    Rakofsky JJ; Schettler PJ; Kinkead BL; Frank E; Judd LL; Kupfer DJ; Rush AJ; Thase ME; Yonkers KA; Rapaport MH
    J Clin Psychiatry; 2013 Nov; 74(11):1084-91. PubMed ID: 24330894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDS-C and IDS-sr: psychometric properties in depressed in-patients.
    Corruble E; Legrand JM; Duret C; Charles G; Guelfi JD
    J Affect Disord; 1999 Dec; 56(2-3):95-101. PubMed ID: 10701466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials.
    Khan A; Khan SR; Shankles EB; Polissar NL
    Int Clin Psychopharmacol; 2002 Nov; 17(6):281-5. PubMed ID: 12409681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients.
    Farabaugh A; Mischoulon D; Fava M; Wu SL; Mascarini A; Tossani E; Alpert JE
    Int Clin Psychopharmacol; 2005 Mar; 20(2):87-91. PubMed ID: 15729083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early improvement in HAMD-17 and HAMD-7 scores predict response and remission in depressed patients treated with fluoxetine or electroconvulsive therapy.
    Lin CH; Park C; McIntyre RS
    J Affect Disord; 2019 Jun; 253():154-161. PubMed ID: 31035216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder.
    Recourt K; de Boer P; Zuiker R; Luthringer R; Kent J; van der Ark P; Van Hove I; van Gerven J; Jacobs G; van Nueten L; Drevets W
    Transl Psychiatry; 2019 Sep; 9(1):216. PubMed ID: 31481683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach.
    Inamdar A; Merlo-Pich E; Gee M; Makumi C; Mistry P; Robertson J; Steinberg E; Zamuner S; Learned S; Alexander R; Ratti E
    J Psychopharmacol; 2014 Jun; 28(6):570-81. PubMed ID: 24699061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardized rater training for the Hamilton Depression Rating Scale (HAMD₁₇) and the Inventory of Depressive Symptoms (IDS(C30)).
    Wagner S; Helmreich I; Lieb K; Tadić A
    Psychopathology; 2011; 44(1):68-70. PubMed ID: 21072002
    [No Abstract]   [Full Text] [Related]  

  • 20. The responsiveness of the Hamilton Depression Rating Scale.
    Faries D; Herrera J; Rayamajhi J; DeBrota D; Demitrack M; Potter WZ
    J Psychiatr Res; 2000; 34(1):3-10. PubMed ID: 10696827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.